Application of RNAi to cancer research and therapy

Fischer L Tan1, James Q Yin

  • 1National laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101.

Insights

RNA interference (RNAi) uses double-stranded RNA (dsRNA) to degrade specific messenger RNAs (mRNAs), offering a powerful tool for gene therapy. This review explores RNAi

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Cancer Research

Background:

  • RNA interference (RNAi) is a natural biological process where double-stranded RNA (dsRNA) directs the degradation of specific messenger RNAs (mRNAs).
  • This gene-silencing mechanism is highly specific and can be harnessed to control gene expression.
  • RNAi technology has become a valuable tool in biological research for gene function elucidation and pathway analysis.

Purpose of the Study:

  • To review the diverse applications of RNA interference in cancer gene therapy.
  • To highlight the potential of RNAi for genome-scale screens, target identification, and validation in cancer research.
  • To discuss the utility of RNAi in functional analysis and the development of animal models for various diseases.

Main Methods:

  • Review of existing literature on RNA interference technology and its applications.
  • Analysis of studies employing RNAi for gene manipulation in mammalian and human cells.
  • Examination of research focused on RNAi-based drug development for cancer and other diseases.

Main Results:

  • RNAi enables precise manipulation of gene expression, facilitating target identification and validation.
  • The technology is instrumental in performing whole-genome screens to uncover gene functions.
  • RNAi has shown significant promise in preclinical studies for cancer gene therapy and disease modeling.

Conclusions:

  • RNA interference represents a breakthrough technology with vast potential in cancer gene therapy.
  • Its applications span from fundamental research to the development of novel therapeutic strategies.
  • Further research and development are crucial for translating RNAi's potential into clinical benefits for various diseases.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...